The serological profile and molecular basis of a new partial D phenotype, DHR

Vox Sanguinis

Volumn 73, Issue 4, 1997, Pages 252-256

  Jones, Jeff W ^a,b   Finning, K ^b   Mattock, R ^c   Williams, M ^d   Voak, D ^e   Scott, M L ^b   Avent, N D ^b  

^a Mersey and North Wales Blood Centre   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^d Yorkshire Heart Centre   (United Kingdom)

^e East Anglian Blood Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP E ANTIGEN; EPITOPE; RHESUS D ANTIGEN;

AMINO ACID SUBSTITUTION; ARTICLE; DNA SEQUENCE; EPITOPE MAPPING; EXON; GENE CONVERSION; HUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY;

EID: 0030716461     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.7340252.x     Document Type: Article

References (29)

1. Lomas C, Tippett P, Thompson KM, Melamed MD, Hughes-Jones NC: Demonstration of seven epitopes on the Rh antigen D using human monoclonal anti-D antibodies and red cells from D categories. Vox Sang 1989;57:261-264.
2. II cells with monoclonal anti-D. Transfus Med 1993;3:67-69.
3. Jones J, Scott ML, Voak D: Monoclonal anti-D specificity and Rh D structure: Criteria for selection of monoclonal anti-D reagents for routine typing of patients and donors. Transfus med 1995;5:171-184.
4. Tippett P, Lomas-Francis C, Wallace M: The Rh antigen D: Partial D antigens and associated 1 coincidence antigens. Vox Sang 1996;70:123-131.
5. Tippett P: Sub-divisions of the Rh (D) antigen. Med Lab Sci 1988;45:88-93.
6. Lomas C, Grassman W, Ford D, Watt J, Gooch A, Jones J, Beolet M, Stern D, Wallace M, Tippett P: FPTT is a low-incidence Rh antigen associated with a 'new' partial Rh D phenotype, DFR. Transfusion 1994;34:612-616.
7. HMii using monoclonal anti-D. Vox Sang 1995;69:236-241.
8. Har antigenic complex is associated with a limited number of D epitopes and alloanti-D production: A study of three unrelated persons and their families. Transfusion 1996;36:104-108.
9. Colin Y, Cherif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron JP: Genetic basis of the Rh D-positivc and Rh D-negative blood group polymorphism as determined by Southern blotting. Blood 1991;78:2747-2752.
10. Avent ND, Ridgwell K, Tanner MJA, Anstee DJ: cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression. Biochem J 1990;271:821-825.
11. Avent ND, Butcher SK, Liu W, Mawby WJ, Mallinson G, Parsons SF, Anstee DJ, Tanner MJA: Localization of the C-termini or the Rh (Rhesus) polypeptides to the cytoplasmic face of the human erythrocyte membrane. J Biol Chem 1992;267:15134-15139.
12. Eyers SAC, Ridgwell K, Mawby WJ, Tanner MJA: Topology and organisation of human Rh (Rhesus) blood group-related polypeptides. J Biol Chem 1994;269:6417-6423.
13. Anstee DJ, Tanner MJA: Biochemical aspects of the Rh (Rhesus) antigens. Bailliere's Clin Haematol 1993;6:401-422.
14. Cartron JP: Defining the Rh blood group antigens. Blood Rev 1994;8:199-212.
15. Har phenotypes. Transfusion 1995;35:51S.
16. Rouillac C, Colin Y, Hughes-Jones NC, Beolet M, D'Ambrosio AM, Cartron JP, Le Van Kim C: Alteration of D epitopes on hybrid Rh proteins resulting from segmental exchanges between the blood group RHD and RHCE genes. Blood 1995;85:2937-2944.
17. VI category phenotype. Blood 1994;83:1129-1135.
18. VII category blood group phenotype. Am J Haematol 1995;49:87.
19. II: Localisation of residues critical for epD3, 4 and 9 expression. Transfus Med 1996;6(suppl 2):O27.
20. HMii. Transfus Med 1996;6(suppl 2):O28.
21. Jones JW, Lloyd-Evans P, Kumpel BM: Quantitation of Rh D antigen sites on weak D and D variant red cells by flow cytometry. Vox Sang 1996;71:176-183.
22. Temple GF, Chang JG, Kan YW: Authentic beta-globin mRNA sequences in homozygous betu-O-thalassemia. Proc Natl Acad Sci USA 1977;74:3047.
23. Sumbrook J, Kritseh EF, Maniatis T: Molecular Cloning, a Laboratory Manual. ed 2. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989.
24. Melamid MD, Thompson KM, Gibson T, Hughes-Jones NC. Requirements for the establishment of heterohybridomas secreting monoclonal human antibody to rhesus (D) blood group antigen. J Immuno1 Methods 1987;104:245-251.
25. VI - a superior typing reagent. Transfus Med 1993:3(suppl 1):P8.
26. Scott ML, Voak D, Jones J, Campbell G: An example of an Rh D variant whoso reaction pattern with monoclonal antibodies splits epiiope D6/7 and sub-splits epitope D2. Transfus Med 1994:4(suppl 1):P71.
27. Apoil PA, Blancher A, Reid M, Roubinet I: Reactivity of anti-D monoclonal IgG by immuno-blotting.Transfus Clin Biol 1996;3:PIA16 16s.
28. Liu W, Smythe J, Jones JW, Scott ML, Voak D, Avent ND: Site-directed inutagenesis of the Rh D antigen: EpD3 and EpD9 require amino acid residues 350, 353 and 354 within the sixth external domain of the Rh D protein. Transfus Clin Bio 1996;3:PIC 10 35s.
29. Voak D, Scott ML, Jones J, Avent N: Monoclonal anti-D epitope specificity - reagents for typing both donors and patients. Proc 24th ISBT Congress, 1996. SY4B II 05.